Literature DB >> 25176014

Neprilysin inhibition--a novel therapy for heart failure.

Mariell Jessup1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25176014     DOI: 10.1056/NEJMe1409898

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Precision medicine in cardiology.

Authors:  Elliott M Antman; Joseph Loscalzo
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 2.  Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy.

Authors:  Ruth Hsiao; Barry Greenberg
Journal:  Curr Heart Fail Rep       Date:  2016-08

3.  European society of cardiology and transcatheter cardiovascular therapeutics.

Authors:  Walter Alexander
Journal:  P T       Date:  2014-11

Review 4.  Advance for Cardiovascular Health in China.

Authors:  Yihua Bei; Chao Shi; Zhongrong Zhang; Junjie Xiao
Journal:  J Cardiovasc Transl Res       Date:  2018-12-07       Impact factor: 4.132

Review 5.  Neprilysin Inhibitors in Cardiovascular Disease.

Authors:  Guson Kang; Dipanjan Banerjee
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

Review 6.  Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

Authors:  Alessia Buglioni; John C Burnett
Journal:  Clin Chim Acta       Date:  2014-10-23       Impact factor: 3.786

Review 7.  Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications.

Authors:  Nikhil Bassi; Gregg C Fonarow
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

8.  Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?

Authors:  Luis Cláudio Lemos Correia; Anis Rassi
Journal:  Arq Bras Cardiol       Date:  2016-01       Impact factor: 2.000

Review 9.  Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond.

Authors:  Jagdeep S S Singh; Chim C Lang
Journal:  Vasc Health Risk Manag       Date:  2015-06-01

Review 10.  Emerging Novel Therapies for Heart Failure.

Authors:  Anthony M Szema; Sophia Dang; Jonathan C Li
Journal:  Clin Med Insights Cardiol       Date:  2015-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.